Unknown

Dataset Information

0

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia.


ABSTRACT: Chronic lymphocytic leukemia (CLL) is characterized by an acquired immune dysfunction. CLL cells affect the phenotype and function of the entire spectrum of innate and adaptive immune cells, including monocytes, T cells, and natural killer (NK) cells, leading to a tumor-supportive environment and reduced immunosurveillance. Novel immunotherapies like immune checkpoint blockade, bi- and tri-specific antibodies, and chimeric antigen receptor (CAR) T cells use the patients' immune system to induce therapeutic responses. Although these novel immunotherapies showed impressive results in several B cell lymphomas, responses in CLL were often disappointing. The strong immunomodulatory effect of CLL is believed to play a pivotal role in the low response rates to these immunotherapeutic strategies. In this review, we summarize how CLL influences the function of non-malignant lymphocytes, with a special focus on T and NK cells, two important cellular mediators for immunotherapy. Secondly, we provide a short overview of the activity of several immunotherapeutics in CLL, and discuss how novel strategies may overcome the disappointing response rates in CLL.

PROVIDER: S-EPMC6747204 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8223062 | BioStudies
| S-EPMC8067870 | BioStudies
| S-EPMC5049355 | BioStudies
| S-EPMC8745474 | BioStudies
| S-EPMC8123840 | BioStudies
| S-EPMC8526014 | BioStudies
| S-EPMC6924557 | BioStudies
| S-EPMC6436008 | BioStudies
| S-EPMC6770225 | BioStudies
| S-EPMC7482503 | BioStudies